Insider Trading March 16, 2026

Root Inc. CAO Sells $170,079 in Stock as Shares Trade Near Yearly Low

Transaction executed under a 10b5-1 plan; company posts mixed Q4 2025 results and receives lower price target from KBW

By Derek Hwang ROOT
Root Inc. CAO Sells $170,079 in Stock as Shares Trade Near Yearly Low
ROOT

Root, Inc. Chief Administrative Officer Jonathan Allison sold 3,900 Class A shares on March 12, 2026, for $43.61 each, totaling $170,079. The sale was made under a pre-arranged 10b5-1 plan and follows the insurer's Q4 2025 results showing strong revenue growth but a slight decline in net income due to higher operating expenses. Keefe, Bruyette & Woods cut its price target to $104 from $150 while keeping an Outperform rating.

Key Points

  • Insider transaction: Jonathan Allison sold 3,900 Class A shares on March 12, 2026, at $43.61 per share for a total of $170,079; the sale was executed under a 10b5-1 trading plan and disclosed on a Form 4.
  • Company performance: Root reported strong revenue growth in Q4 2025 but experienced a slight fall in net income driven by increased operating expenses; a lower loss ratio helped results but did not fully offset higher costs.
  • Market reaction and valuation: Shares were trading near their 52-week low of $42.65 at the time of the sale, far below the 52-week high of $181.14; InvestingPro lists Root among its Most Undervalued names while KBW cut its price target to $104 from $150 but retained an Outperform rating.

Root, Inc. (NASDAQ: ROOT) reported an insider stock sale this week as Chief Administrative Officer Jonathan Allison disposed of 3,900 shares of Class A Common Stock on March 12, 2026. The shares were sold at $43.61 apiece, producing total proceeds of $170,079, according to a Form 4 filing with the Securities and Exchange Commission.

The transaction was carried out pursuant to a pre-established 10b5-1 trading plan, the filing shows. Following the sale, Allison retains direct ownership of 89,979 Root shares.

At the time of the sale, Root stock was trading close to its 52-week low of $42.65, a long way down from its 52-week high of $181.14. Analysis from InvestingPro, cited in company disclosures, characterizes the shares as appearing undervalued at current market levels and lists Root among the platform's Most Undervalued names.


Recent financial results

Root released fourth-quarter 2025 financial results that highlighted robust revenue growth for the period. The company did report a slight reduction in net income, a decline the firm attributed to increased operating expenses. Management noted a lower loss ratio that contributed positively to the quarter, but the benefit was partially offset by higher operating costs.

In the wake of the earnings and company guidance for 2026, Keefe, Bruyette & Woods lowered its price target on Root to $104 from $150 while maintaining an Outperform rating. The firm cited the quarter's performance and Root's forward guidance as factors in the downward revision.


Implications and context

The insider sale, disclosed in a public SEC filing and executed under a structured trading arrangement, coincides with a period of mixed financial signals for Root: strong top-line growth offset by pressure on net income from operating expenses. Market commentary from InvestingPro that the stock appears undervalued sits alongside an analyst price-target reduction from KBW that nevertheless keeps an Outperform view.


Summary

  • Jonathan Allison sold 3,900 Class A shares on March 12, 2026, at $43.61 per share for $170,079.
  • The sale was executed under a pre-arranged 10b5-1 plan and was disclosed in a Form 4 filing.
  • Root reported strong Q4 2025 revenue growth but a modest decline in net income due to higher operating expenses; KBW trimmed its price target to $104 from $150 while keeping an Outperform rating.

Risks

  • Elevated operating expenses contributed to a slight decline in net income for Q4 2025 - this could continue to pressure profitability and affects the financials of the insurance sector.
  • Analyst price-target reduction by Keefe, Bruyette & Woods reflects uncertainty around near-term performance and 2026 guidance - equity valuations in the insurance and financial sectors may be sensitive to updates.
  • Insider selling, even when executed under a 10b5-1 plan, can be perceived negatively by some market participants, potentially affecting investor sentiment in the short term.

More from Insider Trading

Arq General Counsel Makes Small Insider Purchase as Company Navigates Operational Hurdles Mar 16, 2026 Howard Hughes General Counsel Buys $81,206 in Company Stock Mar 16, 2026 Warner Bros. Discovery Director Sells $962K in Stock as Deal Activity Drives Analyst Moves Mar 16, 2026 Canada Pension Plan Investment Board Disposes $213.85 Million in California Resources Stock Mar 16, 2026 Extra Space Storage CEO executes $1.07M stock sale amid firm earnings beat and analyst reassessment Mar 16, 2026